Lek reports increase in revenue, decrease in profit

Ljubljana, 15 August - Slovenia-based pharma company Lek, which is part of the Swiss giant Novartis, recorded a 5.4% increase in sales revenue to EUR 895.3m in 2016. Operating profit fell by 15.5% to EUR 75.4m and net profit by 35.5% to EUR 74.8m.